从随机对照试验中获得的疗效结果是否转化为复发性复发性多发性硬化症观察性研究的疗效数据?
Stefan Verweij1,2, Wouter Ahmed3, Guiling Zhou1
1Unit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, Groningen, The Netherlands.
Pharmacoepidemiology and drug safety
|May 9, 2024
概括
复发性复发性多发性硬化症的观察性研究通常与随机对照试验一致,尽管估计可能因大小和精度而异. 现实世界的证据可以补充试验数据,帮助推断到不同的患者群体.
科学领域:
- 临床流行病学 临床流行病学
- 药物监督 药物监督 药物监督
- 神经学 神经学
背景情况:
- 随机对照试验 (RCT) 是监管决策的基准,因为观察研究的局限性.
- 从观察性研究中获得的真实世界证据 (RWE) 在特定的背景下可能是有价值的.
- 本综述比较了从RCT和观察性研究中使用多发性硬化症疗法作为案例的效果估计.
研究的目的:
- 为了比较随机对照试验 (RCT) 和观察性研究之间的效果估计.
- 评估药物治疗复发性复发性多发性硬化症发现的一致性.
- 评估现实世界的证据在补充关键试验数据的实用性.
主要方法:
- 进行了RCT和观察性研究的系统审查.
- 使用网络元分析和后预测分布进行比较.
- 主要结局:年化复发率;分析药物特定率比率.
主要成果:
- 观察性研究产生了比RCT更高的数值和更低的精度的估计.
- 在28项治疗比较中,有20项显示研究设计之间的比率比率相似.
- 七个不一致性与两种特定的疾病修饰疗法有关.
结论:
- 在考虑后期预测分布时,观察性研究估计在很大程度上与RCT一致.
- 多重观察性研究可以补充复发性复发性多发性硬化症的RCT.
- RWE可能有助于将试验结果推断到更广泛的患者群体.
相关概念视频
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
What is an Experiment?
11.4K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
11.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


